A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2009
11/10/2009	US7615215 Endothelial growth factor specific immunoglobulin for use in diagnosis, prevention and treatment of vision, inflammatory, diabetic and cell proliferative disorders
11/10/2009	US7615214 For abnormal angiogenesis, such as proliferation or metastasis of solid tumors, arthritis in rheumatoid arthritis, diabetic retinopathy, retinopathy of prematurity, psoriasis
11/10/2009	US7615213 Respiratory disorders (asthma); atopic disorders (allergic rhinitis); inflammatory and/or autoimmune conditions of the skin ( atopic dermatitis), and gastrointestinal organs ( inflammatory bowel diseases (IBD)), as well as fibrotic and cancerous disorders
11/10/2009	US7615212 Administering to the joint having systemic onset juvenile idiopathic arthritis an active agent that will reduce the bioavailability of interleukin-1 beta (IL-1 beta) by modifying the transcription, translation or gene expression or by blocking the IL-1 beta recepter;antiinflammatory agent; antipyretics
11/10/2009	US7615211 CD70 inhibition for the treatment and prevention of inflammatory bowel disease
11/10/2009	US7615210 Treatment of endometriosis
11/10/2009	CA2479476C Compositions and methods for the treatment of tumor
11/10/2009	CA2476257C O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
11/10/2009	CA2251027C Defective viral vaccine particles obtained in vivo or ex vivo
11/05/2009	WO2009135199A2 Vaccine compositions and methods
11/05/2009	WO2009135118A2 Lyme disease vaccine
11/05/2009	WO2009135019A2 Methods and compositions for prostate cancer immunotherapy
11/05/2009	WO2009135001A2 Methods and compositions for regulating th2 and th17 responses
11/05/2009	WO2009134976A1 Potent conjugates and hydrophilic linkers
11/05/2009	WO2009134952A2 Potent conjugates and hydrophilic linkers
11/05/2009	WO2009134805A2 Antibodies to granulocyte-macrophage colony-stimulating factor
11/05/2009	WO2009134769A1 Nanoparticles for use in pharmaceutical compositions
11/05/2009	WO2009134738A1 Responses to immunizations in rheumatoid arthritis patients treated with a cd20 antibody
11/05/2009	WO2009134717A1 Chimeric west nile/dengue viruses
11/05/2009	WO2009134489A2 Blockage of interferon-gamma for prevention of polymicrobial synergy
11/05/2009	WO2009134401A2 Methods of inhibiting infection by diverse subtypes of drug-resistant hiv-1
11/05/2009	WO2009134389A2 An anti-cd137 antibody as an agent in the treatment of inflammatory conditions
11/05/2009	WO2009134027A2 Anti-nucleic acid antibody inducing cell death of cancer cells and composition for preventing or treating cancers comprising the same
11/05/2009	WO2009133951A1 Anti-perspiration antigen monoclonal antibody
11/05/2009	WO2009133882A1 Bacterial toxin vaccine
11/05/2009	WO2009133863A1 Immunopotentiating agent comprising ep1 agonist
11/05/2009	WO2009133521A2 Antibodies and vaccines for use in therapeutic and diagnostic methods for alpha-synuclein-related disorders
11/05/2009	WO2009133452A1 Anti-hmga1 monoclonal antibodies, process for their preparation and their use for the quantitative determination of hmga1
11/05/2009	WO2009133378A2 Products and methods for stimulating an immune response
11/05/2009	WO2009133103A1 Inhibitors of gm-csf and il-17 for therapy
11/05/2009	WO2009132939A1 Compositions for treating an inflammatory autoimmune condition
11/05/2009	WO2009132876A1 Cytotoxic immunoglobulin
11/05/2009	WO2009132821A1 Interleukin (il-21) binding proteins and methods of making and using same
11/05/2009	WO2009132660A1 Agents binding to megalin or sex hormone binding globulin and compositions therof for treatment of steroid dependent cancers
11/05/2009	WO2009132484A1 Lytic proteins of vero cell, preparation method thereof and detection kit for vero hcp comprising the same
11/05/2009	WO2009109643A3 Use of interleukin-1 conjugates in the treatment of diabetes
11/05/2009	WO2009108372A3 Antibodies as t cell receptor mimics, methods of production and uses thereof
11/05/2009	WO2009105673A3 Tumor therapy with replication competent sindbis viral vectors
11/05/2009	WO2009105534A3 Ophthalmic nsaids as adjuvants
11/05/2009	WO2009105192A3 Use of saccharides cross-reactive with bacillus anthracis spore glycoprotein as a vaccine against anthrax
11/05/2009	WO2009104074A3 Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells
11/05/2009	WO2009093014A3 Vaccines
11/05/2009	WO2009088837A3 Methods and products to target, capture and characterize stem cells
11/05/2009	WO2009088572A3 Method of treating erythropoietin hyporesponsive anemias
11/05/2009	WO2009086072A3 Therapy of rituximab-refractory rheumatoid arthritis patients
11/05/2009	WO2009077854A3 Adjuvanted glucans
11/05/2009	WO2009059325A3 Multitype hpv peptide compositions and methods for treatment or prevention of human papillomavirus infection
11/05/2009	WO2009029883A3 Methods and compositions for modulating t cells
11/05/2009	WO2009023311A9 Transcutaneous delivery of therapeutic agents
11/05/2009	WO2008147847A9 Immune complex vaccination as a strategy to enhance immunity in the elderly and other immune compromised populations
11/05/2009	WO2008110379A8 Monoclonal antibodies for treatment of cancer
11/05/2009	WO2008079713A8 Methods for the treatment of lada and other adult-onset autoimmune diabetes using immunosuppressive monoclonal antibodies with reduced toxicity
11/05/2009	WO2008060705A8 Anti-dll4 antibodies and methods using same
11/05/2009	US20090275738 Use of A33 antigens and jam-it
11/05/2009	US20090275737 Immunogenic compositions and uses thereof
11/05/2009	US20090275644 Novel adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof
11/05/2009	US20090275512 Compositions and methods for treating cardiovascular disease and myocardial infarction with dipeptidyl peptidase inhibitors or b type natriuretic peptide analogues resistant to prolyl-specific dipeptidyl degradation
11/05/2009	US20090275498 Novel peptides
11/05/2009	US20090275124 Methods and Compositions Comprising Anti-Idiotypic Antibodies to Anti-MMP-14 Antibodies
11/05/2009	US20090275102 homologous immunoreactive thio-disulfide oxidoreductases; fusion proteins; fluorescent, radioactive, or enzymatic labels
11/05/2009	US20090275041 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
11/05/2009	US20090274734 Method for obtaining hollow particles
11/05/2009	US20090274730 Compositions and methods for treating inflammation
11/05/2009	US20090274729 Media for clostridium bacterium and processes for obtaining a clostridial toxin
11/05/2009	US20090274728 Mutant Viruses
11/05/2009	US20090274727 Recombinant RSV Virus Expression Systems And Vaccines
11/05/2009	US20090274726 Synthetic gene
11/05/2009	US20090274725 Materials and Methods for Detecting, Preventing, and Treating Retroviral Infection
11/05/2009	US20090274724 Novel recombinant and mutant adenoviruses
11/05/2009	US20090274723 Modified vaccinia ankara virus vaccine
11/05/2009	US20090274719 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/05/2009	US20090274718 Chimeric proteins that induce effects directed against viruses
11/05/2009	US20090274717 Genes and proteins, and their use
11/05/2009	US20090274716 Lage-1 tumor associated nucleic acids
11/05/2009	US20090274715 Tick chitinase
11/05/2009	US20090274714 Tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules and related anti-cancer vaccine
11/05/2009	US20090274713 Cross-linkers and their uses
11/05/2009	US20090274712 Compositions for coating cell membranes and methods of use thereof
11/05/2009	US20090274711 LEVELS OF BLyS/APRIL HETEROTRIMERS IN SERUM AND USE IN DIAGNOSTIC METHODS
11/05/2009	US20090274710 Trans-membrane-antibody induced inhibition of apoptosis
11/05/2009	US20090274709 Lipocalin-2 As A Prognostic and Diagnostic Marker For Heart And Stroke Risks
11/05/2009	US20090274708 Recombinant Toxin Fragments
11/05/2009	US20090274707 Anti-IL-12 Antibodies, Nucleic Acids Encoding Antibodies, and Methods of Production
11/05/2009	US20090274706 Antibodies to granulocyte-macrophage colony-stimulating factor
11/05/2009	US20090274705 Il-13 binding agents
11/05/2009	US20090274704 Anti-staphylococcus aureus antibodies
11/05/2009	US20090274703 Methods of treating inflammation using IL-17 antagonists
11/05/2009	US20090274702 Method of treatment and Agents useful for same
11/05/2009	US20090274701 Chlamydia pneumoniae polynucleotides and uses thereof
11/05/2009	US20090274700 Il-31 receptor antibodies
11/05/2009	US20090274699 Ul16 binding protein 4
11/05/2009	US20090274698 Combination anti-cancer therapy
11/05/2009	US20090274697 Monoclonal Antibodies That Specifically Block Biological Activity Of A Tumor Antigen
11/05/2009	US20090274696 Methods for treating inflammation
11/05/2009	US20090274695 Inhibition of urokinase-type plasminogen activator (uPA) activity
11/05/2009	US20090274694 Cytokine receptor zcytor17 multimers
11/05/2009	US20090274693 Method of Treating Cancer using a cMet and AXL Inhibitor and an ErbB Inhibitor
11/05/2009	US20090274692 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
11/05/2009	US20090274691 Use of CD25 binding molecules in steroid-resistant patients
11/05/2009	US20090274690 Stimulating remyelination of central nervous system axons by administering a monoclonal antibody characterized by their ability to bind structures and cells within the central nervous system, including oligodendrocytes; including neural dysfunction caused by spinal cord injury

1 ... 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 ... 1823